Abstract
Fifteen patients with malignant tumors involving the liver were treated with hepatic intraarterial injection of yttrium 90 microsphres. With the exception of one patient, no acute or long-term side effects were noted. Four patients are alive and functionally active with follow-up periods of 6, 6, 9, and 12 months. Vascularity of the metastases, absence of extrahepatic disease, and performance status prior to treatment were determining factors for a successful result.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
